论文部分内容阅读
目的:研究重组人表皮细胞生长因子联合利福平油纱治疗烧伤残余肉芽创面的临床效果,为烧伤后期治疗提供临床依据。方法:回顾2010年5月~2013年5月烧伤患者56例,将其分成实验组32例,对照组24例,采用单用碘伏油纱治疗对照组患者,采用重组人表皮细胞生长因子联合利福平油纱治疗实验组患者,治疗结束后,对比两组患者的临床疗效。结果:与对照组相比,实验组患者创面修复的效果更佳,从细菌总转阴率角度看,对照组为23%,实验组为72%,两组数据对比,P<0.01具有高度统计学意义;从创伤面愈合时间角度看,对照组为(29.6±8.72)d,实验组为(20.36±5.98)d,两组数据对比,P<0.05具有统计学意义。结论:采用重组人表皮细胞生长因子联合利福平油纱治疗烧伤残余肉芽创面,效果良好,可提高细菌转阴率,缩短其创面平均愈合时间,值得在临床上推广、应用。
Objective: To study the clinical effect of recombinant human epidermal growth factor combined with rifampicin yam on the treatment of burn residue granulation wounds, and to provide a clinical basis for the treatment of post burn wounds. Methods: Fifty-six burn patients from May 2010 to May 2013 were retrospectively divided into experimental group (32 cases) and control group (24 cases). Patients in the control group were treated with iodophor oil alone. Recombinant human epidermal growth factor Rifampicin gauze treatment group patients, after treatment, the clinical efficacy of two groups were compared. Results: Compared with the control group, wound healing in the experimental group was better than that in the control group. From the perspective of total bacterial negative rate, the control group was 23% and the experimental group was 72% Significance of the study; from the wound healing time point of view, the control group was (29.6 ± 8.72) d, the experimental group was (20.36 ± 5.98) d, the two groups of data, P <0.05 was statistically significant. Conclusion: Recombinant human epidermal growth factor combined with rifampicin yam can effectively improve the rate of bacterial negative conversion and shorten the wound healing time. It is worth to be popularized and applied clinically.